Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. David Jagielski(Eli Lilly): ...

Two of these potential indications, Alzheimer's disease and metabolic dysfunction-associated steatohepatitis, look particularly ... Ever feel like you missed the boat in buying the most successful ...

Terns Pharmaceuticals, Inc.’s TERN share price has surged by 14.97%, which has investors questioning if this is right time to ...

And sometimes you can find stocks that are especially great bargains. Three Motley Fool contributors believe they've done just that. Here's ...

Alnylam Pharmaceuticals, Inc.’s ALNY share price has surged by 11.75%, which has investors questioning if this is right time ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

In my view, the stock is unlikely to match analysts' projections by this time next year, but it still looks like a terrific ... dysfunction-associated steatohepatitis, also performed well in ...

Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025 Announced Positive Top-Line 16-Week Results from the Phase 2a Trial of DA-1241 ...